Wednesday 19 March 2014

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Biography

(Source google.com)
Lung diseases can be congenital or acquired after birth. Many lung diseases are life-threatening, or lead to chronic morbidity (debility). Millions of people in the United States and world-wide are affected by lung disease of one kind or another. Life-saving surfactant therapy for respiratory distress syndrome (RDS), which occurs in infants born prematurely, was developed at Cincinnati Children’s by Dr. Whitsett. This therapy alone has resulted in a major reduction in perinatal deaths in the United States and countries world-wide. In a similar manner, groups in our division are actively seeking new  reatments and therapies for many other lung diseases that affect children and adults. Using a wealth of cutting-edge approaches (many of which have been developed in our division) our groups work on the pathogenesis (causes) of lung diseases with the goal of identifying new therapeutic targets. Some of the lung diseases being studied in the Division of Pulmonary Biology include:
udicious use of antibiotics can decrease adverse effects of antibiotics as well as decrease costs. But more importantly, decreased antibiotic usage will prevent the rise of drug resistant bacteria, which is now a growing problem in the world. Health authorities have been strongly encouraging physicians to decrease the prescribing of antibiotics to treat common upper respiratory tract infections because antibiotic usage does not significantly reduce recovery time for these viral illnesses. Some have advocated a delayed antibiotic approach to treating URIs which seeks to reduce the consumption of antibiotics while attempting to maintain patient satisfaction. Most studies show no difference in improvement of symptoms between those treated with antibiotics right away and those with delayed prescriptions. Most studies also show no difference in patient satisfaction, patient complications, symptoms between delayed and no antibiotics. A strategy of "no antibiotics" results in even less antibiotic use than a strategy of "delayed antibiotics". However, in certain higher risk patients with underlying lung disease, such as chronic obstructive pulmonary disease (COPD), evidence does exist to support the treatment of bronchitis with antibiotics to shorten the course of the illness and decrease treatment failure. Chronic obstructive pulmonary disease (COPD), which includes emphysema, is an example of an obstructive lung disease where the alveolae rupture, thus causing air to be retained in the lungs and hence limiting now a growing problem in the world. Health authorities have been strongly encouraging physicians to decrease the prescribing of antibiotics to treat common upper respiratory tract infections because antibiotic usage does not significantly reduce recovery time for these viral illnesses. Some have advocated a delayed antibiotic approach to treating URIs which seeks to reduce the consumption of antibiotics while attempting to maintain patient satisfaction. Most studies show no difference in improvement of symptoms between those treated with antibiotics right away and those with delayed prescriptions. Most studies also show no difference in patient satisfaction, patient complications, symptoms between delayed and no antibiotics. A strategy of "no antibiotics" results the available space during inhalation. Asthma is an example of an obstructive lung disease (and of an inflammatory lung disease). It is a disease in which muscles of bronchi contract, making it difficult for air to reach the lungs. One treatment of asthma is to use an inhaler which contains a drug to relax muscles of bronchi. Asthma is a difficulty in breathing causing wheezing due to inflammation of bronchi and bronchioles, this causes a restriction in the airflow into the alveoli. Asthma attacks can be brought on by triggers, such as air pollution, tobacco smoke, factory fumes, cleaning solvents, infections, pollens, dust, foods, cold air, exercise, chemicals and medications. Triggers are highly individual and may not be related to allergens. Many asthmatics are not allergic to common allergens such as mold.

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

Lung Conditions Lungs Diagram of a Smoker after Smoking Cancer Anatomy And Heart Drawing Images AFter Smoking Wee

No comments:

Post a Comment